Drug Shortage Report for THYROGEN
| Report ID | 191764 |
| Drug Identification Number | 02246016 |
| Brand name | THYROGEN |
| Common or Proper name | THYROGEN |
| Company Name | SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | THYROTROPIN ALFA |
| Strength(s) | 0.9MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 2 |
| ATC code | V04CJ |
| ATC description | OTHER DIAGNOSTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-05-03 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-12-18 |
| Company comments | Intermittent Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Allocation has been initiated and will continue through 2023 & 2024. |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Company contact information | Customer service contact info: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2023-12-18 | French | Compare |
| v10 | 2023-12-18 | English | Compare |
| v9 | 2023-05-23 | English | Compare |
| v8 | 2023-05-10 | French | Compare |
| v7 | 2023-05-10 | English | Compare |
| v6 | 2023-05-05 | French | Compare |
| v5 | 2023-05-05 | English | Compare |
| v4 | 2023-05-05 | French | Compare |
| v3 | 2023-05-05 | English | Compare |
| v2 | 2023-05-05 | French | Compare |
| v1 | 2023-05-05 | English | Compare |
Showing 1 to 11 of 11